Literature DB >> 31816352

Characterization of the buccal and gastric transit of orally disintegrating tablets in humans using gamma scintigraphy.

Atsushi Kambayashi1, Kazuhiro Sako2, Hiromu Kondo3.   

Abstract

The present study characterized the buccal cavity-emptying and gastric-emptying kinetics of orally disintegrating tablets (ODTs) in fasted humans using gamma scintigraphy. 111Indium-diethylenetriaminepentaacetic acid and technetium-99 m-labeled ion exchange resin were used as a model soluble drug and insoluble pellet-type drug, respectively, and housed in ODTs. These ODTs were then administered to human subjects with or without ingestion of water, after which scintigraphic images were collected in order to characterize the buccal and gastric transit of the radioactivity. The oral disintegration of the ODTs was extremely rapid, with a mean time of ≤1 min. The buccal emptying of the radioactivity was most rapid for the ODT with a water-soluble radiolabel; however, the ODTs with water-insoluble radiolabels showed buccal emptying with median half-times of ≤2.5 min. The ODT with the soluble radiolabel in subjects without water ingestion showed the most rapid gastric emptying compared with the ODTs with the insoluble radiolabels, the gastric-emptying time of which was highly variable. Further, water ingestion did not markedly affect the gastric-emptying time of the tablets with the water-soluble model drug. The observations in the present clinical study will help clarify the in vivo performance of ODTs in humans.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Buccal emptying; Gamma scintigraphy; Gastric emptying; Orally disintegrating tablets; Orodispersible tablets

Year:  2019        PMID: 31816352     DOI: 10.1016/j.ijpharm.2019.118937

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009

2.  Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design.

Authors:  Robert-Alexandru Vlad; Paula Antonoaea; Nicoleta Todoran; Emöke-Margit Rédai; Magdalena Bîrsan; Daniela-Lucia Muntean; Silvia Imre; Gabriel Hancu; Lénárd Farczádi; Adriana Ciurba
Journal:  Pharmaceutics       Date:  2022-07-14       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.